Shimla, June 8
An advisory on the treatment and management of Covid-19 associated mucormycosis (CAM) and other important considerations issued by the Central Government has been circulated to all districts in the state, a spokesperson for the Health Department said here today.
Himachal Pradesh to receive Covishield supply
Shimla: As many as 24,65,448 vaccine doses have been given to the people of the state till date, out of which a total of 1,04,865 beneficiaries are in the 18-44 age group, a spokesperson of the Health Department said here on Tuesday. Earlier, stock of 1,07,620 Covishield doses was made available to the state. He said that 49,350 vaccine doses were being received on Tuesday. As per schedule communicated by the manufacturer, 40,980 vaccines would be received on June 16, 49,350 vaccines on June 26 and 27,500 vaccine doses would be received by July 2. TNS
The National Task Force has reviewed the treatment of Covid-19 associated mucormycosis and given recommendations on various treatment options. As per the recommendations, Amphotericin B, both in the Amphotericin lipid complex/liposomal and Amphotericin B Deoxycholate forms, is equally efficacious for the treatment of CAM cases. However, the latter was more toxic to kidneys and therefore should be administered along with the monitoring of kidney function and electrolyte imbalance, he added.
He said that at present, there are 17 CAM cases in the state — 7 in Kangra, 2 each in Solan and Shimla, 1 in Mandi and 5 in Hamirpur. Four persons had died of CAM-related complications in the state. — TNS
Says Assembly polls in UT after delimitation of constituenci...
Ghulam Nabi Azad urges PM to restore full statehood before c...
On Afghanistan, it said it is for the Afghan people to decid...
Declare results by July 31, says SC
PLA is reported to have converted temporary ammunition dumps...